131.20
price up icon0.37%   +0.48
 
loading

Merck & Co Inc (MRK) Stock Split History

Merck & Co Inc has split its stock 5 times since its initial public offering (IPO). The first stock split occurred on June 01, 1972 with the ratio of 2-for-1, meaning that for 1 share of MRK owned pre-split, shareholders then owned 2 shares. 4 more splits have been implemented since then. The most recent stock split took place on February 17, 1999 on a 2-for-1 basis.

These splits have increased MRK stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Merck & Co Inc's total market capitalization.

For more detailed information of Merck & Co Inc's stock splits, view the table below:

MRK stock split list

Date Split Ratio
1999-02-17 2 - for - 1
1992-05-26 3 - for - 1
1988-05-26 3 - for - 1
1986-05-27 2 - for - 1
1972-06-01 2 - for - 1

Will Merck & Co Inc Stock Split in 2024?

The answer will depend on the decisions of the company's managers and market volatility. Merck & Co Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when MRK stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Merck & Co Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.

Stock Splits of Industry Leaders

Ticker Symbol Latest Split Date Split Ratio
LLY 1997-10-16 2 - for - 1
JNJ 2001-06-13 2 - for - 1
MRK 1999-02-17 2 - for - 1
AZN 2015-07-27 2 - for - 1
NVS 2000-05-11 2 - for - 1
AMGN 1999-11-22 2 - for - 1
PFE 1999-07-01 3 - for - 1
BMY 1999-03-01 2 - for - 1
GSK 2022-07-22 4 - for - 5
GILD 2013-01-28 2 - for - 1
BIIB 2001-01-18 3 - for - 1
GRFS 2016-01-04 2 - for - 1
AMRN 2008-01-18 1 - for - 10
SCLX 2010-05-07 1 - for - 10
drug_manufacturers_general JNJ
$146.14
price down icon 0.46%
$159.62
price down icon 4.58%
drug_manufacturers_general NVS
$97.44
price down icon 1.64%
$269.98
price up icon 0.22%
drug_manufacturers_general PFE
$25.40
price up icon 0.55%
Cap:     |  Volume (24h):